Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Jan. 17, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

Sage Therapeutics discloses new GABA-A receptor modulators

Jan. 14, 2022

Gilead Sciences synthesizes new HIV antivirals

Jan. 14, 2022

X4 Pharmaceuticals presents new CXCR4 antagonists

Jan. 14, 2022

Medshine Discovery divulges new GTPase KRAS G12C mutant inhibitors

Jan. 14, 2022

Icahn School of Medicine at Mount Sinai patents DYRK1A inhibitors

Jan. 14, 2022

Alchemedicine discovers CK1 and/or TGFBR1 inhibitors

Jan. 13, 2022

Roche synthesizes new Mat2A inhibitors

Jan. 13, 2022

AstraZeneca identifies new PARP-1 inhibitors

Jan. 13, 2022

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...